Moderna launches a large-scale clinical trial for an mRNA-based avian influenza vaccine, building on earlier research in 300 healthy adults that showed promising safety and immune response results.
← News
Medicine Breakthroughs Medicine Breakthroughs Health
Moderna Starts Large Avian Influenza Study Despite Earlier HHS Funding Loss - Infectious Disease Advisor
300 Healthy Adults participants Earlier study participants
Messenger RNA (MRNA) platform Vaccine technology
Large-Scale Study Launched Trial status
MRNA vaccine platform
300 adults in earlier research